Veracyte | VCYT - 税引前利益





税引前利益 変化する 日付
Agenus USD 39.21M 49.82M 2026-03
Agilent USD 408M 44M 2026-03
Anika Therapeutics USD 764K 3M 2025-12
Arrowhead Research USD -178.9M 41.34M 2026-06
Bruker USD 117M 95.1M 2026-06
Heron Therapeutics USD -2.95M 14.54M 2025-12
Illumina USD 260M 103M 2026-06
Intrexon USD -60.48M 27.09M 2024-06
Karyopharm Therapeutics USD -22.39M 17.51M 2026-03
Laboratory Of America USD 8.61B 121.8M 2026-06
Ligand Pharmaceuticals USD -24.26M 81.04M 2026-03
Myriad Genetics USD 4.6M 3.4M 2025-12
Rigel Pharmaceuticals USD -1.03M 7.22M 2024-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Siemens EUR 2.86B 89M 2026-03
Sonic Healthcare AUD 402.01M 53.16M 2025-06
Thermo Fisher Scientific USD 1.73B 389M 2026-03
Veracyte USD 26.52M 3.45M 2026-06
Waters USD 356M 444M 2026-06